Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Almirall and Simcere enter into a licensing agreement for IL-2-mu-Fc
Friday, September 30, 2022Almirall SA a global biopharmaceutical company focused on skin health and Simcere Pharmaceutical GroupHK an innovation and RDdriven pharmaceutical company today announced that they have entered into an exclusive licensing agreement for Simceres IL mu...
McKesson Corporation Extends Pharmaceutical Distribution Agreement With CVS Health
Friday, September 30, 2022McKesson Corporation announced that it has signed an agreement in principle to extend its partnership with CVS Health to distribute pharmaceuticals to mail order and specialty pharmacies retail pharmacies and distribution centers through June We are...
Thermo Fisher Scientific Launches a More Sustainable Solution for Large-Scale Cell Culture Harvesting
Thursday, September 29, 2022Thermo Fisher Scientific Inc the world leader in serving science today unveiled the Thermo Scientific DynaSpin SingleUse Centrifuge system at the BioProcess International annual conference in Boston MA The system is specifically designed to provide a...
Visus Therapeutics Expands Ophthalmic Drug Development Portfolio With Acquisition of ViewPoint Therapeutics’ Assets
Thursday, September 29, 2022Visus Therapeutics Inc a clinical stage biopharmaceutical company focused on developing multitargeted treatments for the eye today announced it has expanded its pipeline via the acquisition of all patents and other assets of ViewPoint Therapeutics In...
Scribe Therapeutics Announces Research Collaboration with Sanofi to Accelerate Breakthrough CRISPR-based Cell Therapies for Cancer
Wednesday, September 28, 2022Scribe Therapeutics Inc a molecular engineering company pioneering a CRISPR by Design platform for genetic medicine today announced a strategic collaboration with Sanofi for the use of Scribes CRISPR genome editing technologies to enable genetic modi...
Koselugo approved in Japan for paediatric patients with plexiform neurofibromas in neurofibromatosis type 1
Wednesday, September 28, 2022Koselugo selumetinib has been approved in Japan for the treatment of paediatric patients three years of age and older with plexiform neurofibromas PNs in neurofibromatosis type NF with clinical symptoms such as pain and disfigurement and PNs which c...
Pulse Biosciences Announces FDA 510(k) Clearance for the Treatment of Sebaceous Hyperplasia
Tuesday, September 27, 2022Pulse Biosciences Inc a novel bioelectric medicine company developing the CellFX System powered by NanoPulse Stimulation NPS technology today announced receipt of US Food and Drug Administration FDA k clearance for its CellFX System expanding the ind...
Atamyo Therapeutics Announces First Patient Dosed with ATA-100 Gene Therapy in LGMD-R9 Clinical Trial
Tuesday, September 27, 2022Atamyo Therapeutics a biotechnology company focused on the development of newgeneration gene therapies targeting neuromuscular diseases today announced the dosing with ATA of a first patient in a phase clinical study in FRKPrelated limbgirdle muscul...
Massive Bio Continues to Grow in Europe
Monday, September 26, 2022Massive Bio which uses its proprietary artificial intelligencebased platform to match cancer patients to clinical trials regardless of where they live or their financial circumstances is expanding its operations in Europe With support from Series B i...
Aptar Pharma Announces Exclusive Collaboration with Fluidda
Friday, September 23, 2022Nanopharm an Aptar Pharma company and leader in contract research and development services for orally inhaled and nasal drug products OINDPs today announced an exclusive collaboration with Fluidda a leader in the field of Functional Respiratory Imagi...
